S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NASDAQ:APLT

Applied Therapeutics Stock Forecast, Price & News

$19.73
-0.49 (-2.42 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.32
Now: $19.73
$20.32
50-Day Range
$19.91
MA: $22.25
$24.15
52-Week Range
$13.58
Now: $19.73
$57.39
Volume147,188 shs
Average Volume83,628 shs
Market Capitalization$443.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.

MarketRank

Overall MarketRank

1.43 out of 5 stars

Medical Sector

511th out of 1,923 stocks

Pharmaceutical Preparations Industry

253rd out of 773 stocks

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APLT
CUSIPN/A
CIKN/A
Phone212-220-9226
Employees22

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$-45,510,000.00

Miscellaneous

Market Cap$443.69 million
Next Earnings Date3/12/2021 (Estimated)
OptionableNot Optionable
$19.73
-0.49 (-2.42 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APLT News and Ratings via Email

Sign-up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied Therapeutics (NASDAQ:APLT) Frequently Asked Questions

How has Applied Therapeutics' stock price been impacted by Coronavirus?

Applied Therapeutics' stock was trading at $29.59 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APLT shares have decreased by 33.3% and is now trading at $19.73.
View which stocks have been most impacted by COVID-19
.

Is Applied Therapeutics a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Applied Therapeutics in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Applied Therapeutics stock.
View analyst ratings for Applied Therapeutics
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Applied Therapeutics?

Wall Street analysts have given Applied Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Applied Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Applied Therapeutics' CEO?

1,448 employees have rated Applied Therapeutics CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Applied Therapeutics' employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Applied Therapeutics' next earnings date?

Applied Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, March 12th 2021.
View our earnings forecast for Applied Therapeutics
.

How were Applied Therapeutics' earnings last quarter?

Applied Therapeutics, Inc. (NASDAQ:APLT) posted its quarterly earnings data on Tuesday, November, 17th. The company reported ($1.33) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.02) by $0.31.
View Applied Therapeutics' earnings history
.

What price target have analysts set for APLT?

5 equities research analysts have issued 12 month price targets for Applied Therapeutics' stock. Their forecasts range from $44.00 to $85.00. On average, they anticipate Applied Therapeutics' share price to reach $63.50 in the next twelve months. This suggests a possible upside of 221.8% from the stock's current price.
View analysts' price targets for Applied Therapeutics
or view Wall Street analyst' top-rated stocks.

Who are some of Applied Therapeutics' key competitors?

What other stocks do shareholders of Applied Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Therapeutics investors own include Enterprise Products Partners (EPD), Pfizer (PFE), Advanced Micro Devices (AMD), Energy Transfer (ET), Micron Technology (MU), NVIDIA (NVDA), Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS) and Raytheon Technologies (RTX).

Who are Applied Therapeutics' key executives?

Applied Therapeutics' management team includes the following people:
  • Dr. Shoshana Shendelman Ph.D., Chairman, Founder, Pres, CEO & Sec. (Age 42, Pay $550k)
  • Dr. Riccardo Perfetti, Chief Medical Officer (Age 62, Pay $757.09k)
  • Mr. Charles Silberstein, CFO & Head of Bus. Devel.
  • Mr. Chids Mahadevan, VP of Fin. & Chief Accounting Officer (Age 52)
  • Mr. Adam Hansard, Chief Commercial Officer

When did Applied Therapeutics IPO?

(APLT) raised $60 million in an initial public offering on the week of May 13th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and UBS Investment Bank acted as the underwriters for the IPO and Baird was co-manager.

What is Applied Therapeutics' stock symbol?

Applied Therapeutics trades on the NASDAQ under the ticker symbol "APLT."

How do I buy shares of Applied Therapeutics?

Shares of APLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied Therapeutics' stock price today?

One share of APLT stock can currently be purchased for approximately $19.73.

How big of a company is Applied Therapeutics?

Applied Therapeutics has a market capitalization of $443.69 million. The company earns $-45,510,000.00 in net income (profit) each year or ($3.55) on an earnings per share basis. Applied Therapeutics employs 22 workers across the globe.

What is Applied Therapeutics' official website?

The official website for Applied Therapeutics is www.appliedtherapeutics.com.

How can I contact Applied Therapeutics?

Applied Therapeutics' mailing address is 340 MADISON AVENUE 19TH FLOOR, NEW YORK NY, 10173. The company can be reached via phone at 212-220-9226 or via email at [email protected]

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.